Begin with the end in mind: designing synthetic antibiotics with a universal mechanism of action
The rising threat of antimicrobial resistance (AMR) is prompting many researchers to investigate potential new antibiotics. Preventing the spread of dangerous bacteria, especially in a hospital environment, could save the lives of many patients who die from conditions such as sepsis.
Drug Target Review’s Victoria Rees spoke to James Graham, Executive Director of Recce Pharmaceuticals, to find out how researchers are attempting to combat harmful bacteria with a novel range of synthetic antibiotics.
Emerging Antimicrobials and Diagnostics in AMR 2023
International Matchmaking Symposium EADA 2023
Amsterdam, The Netherlands